General medicines

Product information:

Health-care Professional Information:

  • November 3, 2009 - Notice to Hospitals - Health Canada Endorsed Important Safety Information (PDF - 30.3 KB) on PrRELENZA (zanamivir) Dry Powder for Inhalation

Consumer Information:

  • “Please read the “Consumer Information” leaflet for RELENZA located on this website as it contains important safety information on RELENZA.”
    Information (PDF - 669 KB)